{
  "pmcid": "6815674",
  "sha256": "ef5a2973246e94192b36c5ba6b82e2a69c8a7e5f4d34411dc404353996d56e6e",
  "timestamp_utc": "2025-11-09T16:10:42.803872+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.271666666666668,
    "reading_ease": 40.37333333333336,
    "word_count": 264
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "patients with resected pancreatic ductal adenocarcinoma (PDA) received either gemcitabine (GEM) or 5-fluorouracil (5-FU) adjuvant monotherapy"
      },
      "Participants": {
        "score": 2,
        "evidence": "Tissue samples from 379 patients with PDA enrolled in the European Study Group of Pancreatic Cancer-3 trial"
      },
      "Intervention": {
        "score": 2,
        "evidence": "patients with resected pancreatic ductal adenocarcinoma (PDA) received either gemcitabine (GEM) or 5-fluorouracil (5-FU) adjuvant monotherapy"
      },
      "Objective": {
        "score": 1,
        "evidence": "We tested cytoplasmic HuR (cHuR) as a predictive marker for response to chemotherapy"
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "There was no association between cHuR expression and prognosis in the overall cohort"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Tissue samples from 379 patients with PDA"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Median DFS for patients with high cHuR was significantly greater for patients treated with 5-FU compared to GEM [20.1 months, confidence interval (CI): 8.3–36.4 vs 10.9 months, CI: 7.5–14.2; P = 0.04]"
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 11,
    "max_score": 25
  }
}